Scientific Reports (Dec 2022)

Clinical features and serum cytokine profiles of elderly-onset adult-onset Still’s disease

  • Mizuki Yagishita,
  • Hiroto Tsuboi,
  • Yuki Kuroda,
  • Tomonori Sawabe,
  • Akira Kawashima,
  • Fumina Kawashima,
  • Nana Uematsu,
  • Ryota Sato,
  • Taihei Nishiyama,
  • Mayu Terasaki,
  • Hirofumi Toko,
  • Fumika Honda,
  • Ayako Ohyama,
  • Saori Abe,
  • Ayako Kitada,
  • Haruka Miki,
  • Shinya Hagiwara,
  • Yuya Kondo,
  • Takayuki Sumida,
  • Isao Matsumoto

DOI
https://doi.org/10.1038/s41598-022-25514-6
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Recent studies have suggested that the clinical features of elderly-onset adult-onset Still’s disease (AOSD) differ from those of young and middle-aged-onset patients, whereas the details remain unclear, and cytokine profiles of elderly-onset AOSD have not been reported. To clarify the clinical features and cytokine profiles of elderly-onset AOSD, we examined patients with AOSD who developed the disease between January 2006 and September 2021. We divided the patients into the young and middle-aged-onset group (aged < 65 years) and the elderly-onset group (aged ≥ 65 years) and compared the groups in terms of patient characteristics, clinical symptoms, laboratory findings including serum interleukin (IL)-6 and IL-18, treatment, and prognosis. A total of 48 patients were examined (10 in the elderly-onset group). In the elderly-onset group, atypical rash was significantly more frequent, typical rash and splenomegaly were significantly less frequent, white blood cell count and neutrophil ratio were significantly higher and serum IL-6 levels were significantly lower. Serum IL-6 showed a significantly negative correlation with age at onset. Treatment and relapse were comparable between the 2 groups, whereas infections were significantly more frequent in the elderly-onset group. The clinical features and cytokine profiles of elderly-onset AOSD might differ from those of young and middle-aged-onset AOSD.